Our results support the need for future mechanistic investigations of whether 16:1n7 and 16:0 as well as hepatic DNL and SCD activity have overlapping or partly independent roles in the pathogenesis of T2D. This evidence concerns the gene SCD and type 2 diabetes mellitus.